​

Reference material formulated for use with multiplex test methods that can detect SARS-CoV-2, flu A/B, and respiratory syncytial virus (RSV). 
 

Three different concentrations of positive reference material (100,000, 10,000 and 1,000 copies/ml)

Negative reference material directed against the human RNase P gene (5,000 copies/ml). 

The panel is optimized for assay verification at installation by documenting test performance along the assay’s range enabling laboratories to establish lower limits of detection (LOD), perform assay comparisons, and evaluate staff proficiency.

Features:

• Non-infectious and replication-deficient, enables safe handling in contrast to viral samples

• Fully extractable with a real viral protein coat; superior to “naked” transcribed RNA

• Includes negative reference material for targeting sequences for the human RNase P

• gene

• 2-year stability at 2 - 8°C

• RUO

Click Here for more product information on our partner site